Article
Pharmacogenomics in Cardiovascular Diseases.
Current protocols - 1 Jul 2021
McDonough Caitrin W
Abstract excerpt
Cardiovascular pharmacogenomics is the study and identification of genomic markers that are associated with variability in cardiovascular drug response, cardiovascular drug-related outcomes, or cardiovascular drug-related adverse events. This overview presents an introduction and historical background to cardiovascular pharmacogenomics, and a protocol for designing a cardiovascular pharmacogenomics study....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
